Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Interest Expenses (2016 - 2019)

Anaptysbio (ANAB) has disclosed Interest Expenses for 4 consecutive years, with $200000.0 as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Interest Expenses fell 45.21% year-over-year to $200000.0, compared with a TTM value of $200000.0 through Sep 2020, down 83.42%, and an annual FY2019 reading of $1.0 million, down 36.99% over the prior year.
  • Interest Expenses was $200000.0 for Q4 2019 at Anaptysbio, down from $240000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $456000.0 in Q4 2017 and bottomed at $111000.0 in Q4 2016.
  • Average Interest Expenses over 4 years is $307875.0, with a median of $342500.0 recorded in 2018.
  • The sharpest move saw Interest Expenses soared 310.81% in 2017, then plummeted 45.21% in 2019.
  • Year by year, Interest Expenses stood at $111000.0 in 2016, then skyrocketed by 310.81% to $456000.0 in 2017, then dropped by 19.96% to $365000.0 in 2018, then plummeted by 45.21% to $200000.0 in 2019.
  • Business Quant data shows Interest Expenses for ANAB at $200000.0 in Q4 2019, $240000.0 in Q3 2019, and $281000.0 in Q2 2019.